Phase Ib Clinical Study to Evaluate the Safety and Tolerability of VSA012 Injection in Paroxysmal Nocturnal Hemoglobinuria
Clinical trial NCT06848296 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06848296
- Sponsor
- Bisirna Therapeutics Pte. Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-15
- Primary completion
- 2027-02-28
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.